When the Food and Drug Administration gave the OK to a new treatment for a parasitic disease called leishmaniasis in late March, the Canadian company that owns the medicine got something that's quite likely to prove even more valuable than U.S. sales of the drug will ever be.
Would anyone still "like to buy the world a Coke"?
Yes, it's tough times for Big Soda in the U.S. The numbers alone make it clear. "The entire [U.S.] carbonated soft drink category has been down for nine years," says John Sicher, editor of Beverage Digest. "Diet [soft drinks] are declining at a steeper pace than sugared [soft drinks]," likely because people are concerned about artificial ingredients.